Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 4, 2002, Pages 589-592

  Reinhardt, A K ^a   Kempf, I ^a   Kobisch, M ^a   Gautier Bouchardon, A V ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ENROFLOXACIN; LEUCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC CODE; IN VITRO STUDY; MYCOPLASMA GALLISEPTICUM; NONHUMAN; SEQUENCE ANALYSIS;

MYCOPLASMA GALLISEPTICUM;

EID: 0036800463     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf158     Document Type: Article

References (10)

1. Ley, D. H. & Yoder, H. W. (1997). Mycoplasma gallisepticum infection. In Diseases of Poultry (Calnek, B. W., Ed.), pp. 194-207. Iowa State University Press, Ames, IA, USA.
2. Reinhardt, A. K., Bébéar, C. M., Kempf, I., Kobisch, M. & Gautier-Bouchardon, A. V. (2002). Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro. Antimicrobial Agents and Chemotherapy 46, 590-3.
3. Freundt, E. A. (1983). Culture media for classic mycoplasmas. In Methods in Mycoplasmology (Tully, J. G. & Razin, S., Eds), pp. 127-35. Academic Press, New York, NY, USA.
4. Bébéar, C. & Robertson, J. (1996). Determination of minimal inhibitory concentration. In Molecular and Diagnostic Procedures in Mycoplasmology (Tully, J. G. & Razin, S., Eds), pp. 189-97. Academic Press, New York, NY, USA.
5. National Committee for Clinical Laboratory Standards. (1999). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Testing for Bacteria Isolated from Animals: Approved Standard M31-A. NCCLS, Wayne, PA, USA.
6. Kellog, D. E. & Kwok, S. (1990). Detection of human immunodeficiency virus. In PCR Protocols: A Guide to Methods and Amplification (Innis, M. A., Gelfand, D. H., Sninsky, J. J. & White, T. J., Eds), pp. 339-43. Academic Press, San Diego, CA, USA.
7. Heisig, P. (1996). Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy 40, 879-85.
8. Kim, J. H., Cho, E. H., Kim, K. S., Kim, H. Y. & Kim, Y. M. (1998). Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates. Antimicrobial Agents and Chemotherapy 42, 190-3.
9. Bébéar, C. M., Charron, A., Bové, J. M., Bébéar, C. & Renaudin, J. (1998). Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis. Antimicrobial Agents and Chemotherapy 42, 2024-31.
10. Bébéar, C. M., Renaudin, H., Charron, A., Gruson, D., Lefrançois, M. & Bébéar, C. (2000). In vitro activity of trovafloxacin compared with those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrobial Agents and Chemotherapy 44, 2557-60.